Mereo BioPharma Group PLC | Balance Sheet
Fiscal year is January-December. All values GBP Thousands.
2015
2016
2017
2018
Cash & Short Term Investments
12,541.30
53,870.90
52,838.00
27,541.90
Total Accounts Receivable
1,049.40
5,805.00
8,368.10
5,886.30
Other Current Assets
253.90
1,102.10
1,970.80
1,066.90
Total Current Assets
13,844.60
60,778.00
63,176.90
34,495.20
Net Property, Plant & Equipment
204.50
173.90
153.40
148.90
Intangible Assets
25,812.90
25,812.90
33,005.20
32,632.20
Total Assets
39,862.10
86,764.80
96,335.50
67,276.30
ST Debt & Current Portion LT Debt
-
-
1,939.80
Other Current Liabilities
3,977.50
3,209.10
7,677.80
Total Current Liabilities
3,977.50
3,209.10
9,617.60
Long-Term Debt
-
3,126.50
19,120.60
Provision for Risks & Charges
141.30
1,172.40
4,075.40
Other Liabilities
-
-
1,346.50
Total Liabilities
4,118.80
7,508.10
34,160.10
Common Equity (Total)
35,743.20
79,256.70
62,175.40
Total Shareholders' Equity
35,743.20
79,256.70
62,175.40
Total Equity
35,743.20
79,256.70
62,175.40
Liabilities & Shareholders' Equity
39,862.10
86,764.80
96,335.50
About Mereo BioPharma Group
View Profile
